MedPath

Response evaluation after chemoradiation for advanced oropharyngeal cancer using PET-CT and MRI

Recruiting
Conditions
Squamous cell carcinoma (SCC), oropharynx
Registration Number
NL-OMON26306
Lead Sponsor
Prof. dr. R. de Bree.Afdeling Keel-, Neus-, en Oorheelkunde/ Hoofd-halschirurgieVU Medisch CentrumDe Boelelaan 11171081 HV Amsterdam+31204443689
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

•Oropharyngeal squamous cell carcinoma

•Initially resectable

Exclusion Criteria

•Age < 18 years

•Pregnancy

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is: accuracy with which diagnostic tests reduce the number of avoided futile EUAs.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoints are: interobserver agreement, SUV (FDG-PET) and ADC (DW-MRI) thresholds, associated costs and burden of diagnostic procedures and health related quality of life.
© Copyright 2025. All Rights Reserved by MedPath